Namodenoson
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Namodenoson, covering 2024-07-31 to 2025-04-29. Get the full timeline:
Most recent: Clinical Trial Update: Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis [Phase 3]